Of (device) taxes, brains & spite

Another Tax Day has come. This year brings a bitter reminder of the perils of U.S. tax policy, particularly the ill-conceived medical device tax. The tax has gobbled an estimated $450 million from manufacturers’ pockets since Jan. 1. While costs could hit $2 billion annually, the true costs in terms of foregone opportunity in medical advances could be incalculable. In an opinion piece in the Wall Street Journal, Siemens Healthcare CEO Gregory Sorenson makes an impassioned appeal on behalf of current and future patients for the repeal of the tax.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.